15,577 Shares in SPDR S&P Pharmaceuticals ETF $XPH Purchased by SummitTX Capital L.P.

SummitTX Capital L.P. bought a new stake in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 15,577 shares of the company’s stock, valued at approximately $843,000. SummitTX Capital L.P. owned 0.25% of SPDR S&P Pharmaceuticals ETF at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Turtle Creek Wealth Advisors LLC bought a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 1st quarter worth approximately $26,000. Royal Bank of Canada grew its position in SPDR S&P Pharmaceuticals ETF by 1.8% in the 4th quarter. Royal Bank of Canada now owns 27,098 shares of the company’s stock valued at $1,518,000 after acquiring an additional 480 shares during the last quarter. Rockefeller Capital Management L.P. increased its stake in SPDR S&P Pharmaceuticals ETF by 3.2% in the fourth quarter. Rockefeller Capital Management L.P. now owns 20,043 shares of the company’s stock worth $1,123,000 after purchasing an additional 627 shares during the period. Advisory Services Network LLC purchased a new stake in SPDR S&P Pharmaceuticals ETF in the third quarter worth $34,000. Finally, Fifth Third Bancorp purchased a new stake in SPDR S&P Pharmaceuticals ETF in the first quarter worth $39,000.

SPDR S&P Pharmaceuticals ETF Trading Up 1.5%

NYSEARCA:XPH opened at $69.74 on Friday. The company has a market cap of $488.18 million, a price-to-earnings ratio of 14.28 and a beta of 0.58. SPDR S&P Pharmaceuticals ETF has a twelve month low of $40.80 and a twelve month high of $70.15. The stock has a fifty day simple moving average of $63.63 and a 200-day simple moving average of $58.91.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.